SMARTRENT INC (SMRT)

US83193G1076 - Common Stock

1.76  -0.04 (-2.22%)

After market: 1.76 0 (0%)

Fundamental Rating

3

Overall SMRT gets a fundamental rating of 3 out of 10. We evaluated SMRT against 127 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of SMRT is average, but there are quite some concerns on its profitability. SMRT is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year SMRT has reported negative net income.
In the past year SMRT had a positive cash flow from operations.
SMRT had negative earnings in each of the past 5 years.
In multiple years SMRT reported negative operating cash flow during the last 5 years.

1.2 Ratios

SMRT's Return On Assets of -4.91% is in line compared to the rest of the industry. SMRT outperforms 40.48% of its industry peers.
SMRT has a Return On Equity (-7.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.91%
ROE -7.08%
ROIC N/A
ROA(3y)-12.13%
ROA(5y)-7.56%
ROE(3y)-17.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SMRT's Gross Margin of 30.94% is in line compared to the rest of the industry. SMRT outperforms 48.41% of its industry peers.
SMRT's Gross Margin has declined in the last couple of years.
SMRT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.17%

6

2. Health

2.1 Basic Checks

SMRT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SMRT has been increased compared to 1 year ago.
The number of shares outstanding for SMRT has been increased compared to 5 years ago.
There is no outstanding debt for SMRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SMRT has an Altman-Z score of 1.37. This is a bad value and indicates that SMRT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SMRT (1.37) is worse than 72.22% of its industry peers.
There is no outstanding debt for SMRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.37
ROIC/WACCN/A
WACC8.58%

2.3 Liquidity

SMRT has a Current Ratio of 3.13. This indicates that SMRT is financially healthy and has no problem in meeting its short term obligations.
SMRT's Current ratio of 3.13 is fine compared to the rest of the industry. SMRT outperforms 62.70% of its industry peers.
A Quick Ratio of 2.78 indicates that SMRT has no problem at all paying its short term obligations.
SMRT has a Quick ratio of 2.78. This is in the better half of the industry: SMRT outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 2.78

4

3. Growth

3.1 Past

SMRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.00%, which is quite impressive.
The Revenue has been growing slightly by 5.24% in the past year.
SMRT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -29.21% yearly.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)5.24%
Revenue growth 3YN/A
Revenue growth 5Y-29.21%
Sales Q2Q%-9.15%

3.2 Future

The Earnings Per Share is expected to grow by 31.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, SMRT will show a quite strong growth in Revenue. The Revenue will grow by 17.81% on average per year.
EPS Next Y47.87%
EPS Next 2Y31.02%
EPS Next 3Y31.68%
EPS Next 5YN/A
Revenue Next Year-10.69%
Revenue Next 2Y-2.15%
Revenue Next 3Y7.36%
Revenue Next 5Y17.81%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SMRT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

SMRT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 353.73
EV/EBITDA N/A

4.3 Compensation for Growth

SMRT's earnings are expected to grow with 31.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.02%
EPS Next 3Y31.68%

0

5. Dividend

5.1 Amount

SMRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SMARTRENT INC

NYSE:SMRT (9/17/2024, 8:04:01 PM)

After market: 1.76 0 (0%)

1.76

-0.04 (-2.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap356.21M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.91%
ROE -7.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 30.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.13
Quick Ratio 2.78
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y47.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.24%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y